| 5hmC | 5-Hydroxymethylcytosine |
| 5hmdC | 5-hydroxymethyl-2′-deoxynytidine |
| 5hmdC | Global DNA hydroxy methylation |
| 5mC | 5-Methylcytosine |
| 5mdC | Global DNA methylation |
| ARC | American College of Rheumatology Criteria |
| BAI | Beck Anxiety Index |
| BDNF | Brain-derived neurotrophic factor |
| BMI | Body mass index |
| C-CPM | Cold effect on conditioned pain modulation |
| COMT | Catecholamine-O-methyltransferase |
| CpG | Cytosine-phosphate-Guanine dinucleotide |
| CPM | Conditioned pain modulation |
| CPT | Cold pain thresholds |
| CSI | Central sensitization inventory |
| CSL | CFS symptom list for ME/CFS-related symptoms |
| DNA | Deoxyribonucleic acid |
| DNMT3a | DNA methyltransferase 3a |
| EM-Seq | Enzymatic methyl-sequencing |
| FM | Fibromyalgia |
| fMRI | Functional magnetic resonance imaging |
| H-CPM | Heat effect on conditioned pain modulation |
| HDAC1 | Histone deacetylase 1 |
| HPLC | High-pressure liquid chromatography |
| HPT | Heat pain thresholds |
| IPAQ | International physical activity questionnaire |
| LC/MS-MS | Liquid chromatography and tandem mass spectrometry |
| MB-COMT | Membrane-bound COMT |
| MBD1 | Methyl-CpG-binding domain 1 |
| ME/CFS | Myalgic encephalomyelitis/chronic fatigue syndrome |
| MeCP2 | Methyl-CpG-binding proteins |
| METs | Metabolic equivalents |
| MOR | µ-Opioid receptor 1 |
| mRNA | Messenger RNA |
| NRS | Numeric Rating Scale |
| OPRM1 | µ-Opioid receptor 1 gene |
| PCA | Principal component analysis |
| PCR | Polymerase chain reaction |
| PCS | Pain catastrophizing scale |
| PET | Positron emission tomography |
| PPT | Pressure pain threshold |
| QST | Quantitative sensory testing |
| RM-LMM | Repeated-measures linear mixed model |
| S-COMT | Soluble COMT |
| SF-36 | Short-form 36 questionnaire |
| TAPSß | TET-assisted pyridine borane sequencing |
| VIF | Variance inflation factor |
| WPI | Widespread Pain Index |